The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Egorov V.I.

Chuvashskiĭ gosudarstvennyĭ universitet im. I.N. Ul'ianova, Vtoraia gorodskaia bol'nitsa, Cheboksary

Mustafaev D.M.

LOR-klinika Moskovskogo oblastnogo nauchno-issledovatel'skogo klinicheskogo instituta im. M.F. Vladimirskogo, Moskva

Kochneva A.O.

The State Budgetary Healthcare Institution of Moscow Area Moscow’s Regional Research Clinical Institute M.F. Vladimirskiy, Moscow, Russia

Papillomatosis of the larynx in children: the current state of the problem

Authors:

Egorov V.I., Mustafaev D.M., Kochneva A.O.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2018;83(5): 84‑90

Read: 13119 times


To cite this article:

Egorov VI, Mustafaev DM, Kochneva AO. Papillomatosis of the larynx in children: the current state of the problem. Russian Bulletin of Otorhinolaryngology. 2018;83(5):84‑90. (In Russ.)
https://doi.org/10.17116/otorino20188305184

Recommended articles:

References:

  1. Ashurov ZM, Zenger VG. Respiratory papillomatosis in children. M.: Mediasphere; 2004. (In Russ.)
  2. Katsenos S, Becker HD. Recurrent respiratory papillomatosis: a rare chronic disease, difficult to treat, with potential to lung cancer transformation: apropos of two cases and a brief literature review. Case Rep Oncol. 2011;4(1):162-71.
  3. Somers GR, Tabrizi SN, Borg AJ, Garland SM, Chow CW. Juvenile laryngeal papillomatosis in a pediatric population: a clinicopathologic study. Pediatr Pathol Lab Med. 1997;17(1):53-64.
  4. Larson DA, Derkay CS. Epidemiology ofrecurrent respiratory papillomatosis. Journal APMIS. 2010;118(6-7):450-454.
  5. Chireshkin DG. Chronic obstruction of the laryngea lpart of the pharynx, larynx and trachea in children. Etiology, clinical features and method sofe limination. M.: Rapid-Print; 1994. (In Russ.)
  6. Lindeberg H, Elbrond O. Laryngeal papillomas: the epidemiology in a Danish subpopulation 1965—1984. Clinical Otolaryngology. 1990;15:125-131.
  7. Bondaryev A, Makris D, Breen DP, Dutau H. Airway Stenting for Severe Endobronchial Papillomatosis Respiration. 2009;77(4):455-458.
  8. Shah KV, Stern WF, Shah FK, Bishai DM, Kashima HK. Risk factors for juvenile — onset recurrent respiratory papillomatosis. Journal Pediatric Research. 1998;43:157.
  9. Syrjanen SM, Syrjanen KJ, Happonen R-P. Human papillomavirus (HPV) DNA sequences in oral precancerous lesions and squamous cell carcinoma demonstrated by in situ hybridization. Journal of Oral Pathology and Medicine. 1988;6:273-278.
  10. Sisk J, Schweinfurth JM, Wang XT, Chong K. Presence of human papillomavirus DNA in tonsillectomy specimens. Laryngoscope. 2006;116:8:1372-1374.
  11. Chen R, Sehr P, Waterboer TJ. Presenceof DNA of human papillomavirus 16 but no other typesin tumor-free tonsillar tissue. Clinical Microbiology. 2005;43:3:1408-1410.
  12. Mammas IN, Sourvinos G. Human papilloma virusin hyperplastic tonsillar and adenoid tissuesin children. The Pediatric Infectious Disease Journal. 2006;25:12:1158-1162.
  13. Ribeiro KMX, Alvez JM. Detection of human papillomavirus in the tonsils of children undergoing tonsillectomy. Brazilian Journal of Infectious Disease. 2006;10:3:165-168.
  14. Zur Hausen H, de Villiers EM. Human papillomaviruses. Annual Review of Microbiology. 1994;48:427-447.
  15. Gomez MA, Drut R, Lojo MM, Drut RM. Detection of human papillomavirus in juvenile laryngeal papillomatosis using polymerase chain reaction. Annals of Dermatology. 1993;5(1):1-5.
  16. Sidorenko SI. Preparations of interferon and its inducers in complex therapy of juvenile erespiratory papillomatosis: Dis. PhD. M. 2001. (In Russ.)
  17. Bonagura VR, Hatam L, DeVoti J, Feifei Zeng, Steinberg BM. Recurrent respiratory papillomatosis: Altered CD8+ T-Cell subsets and TH1/TH2 cytokine imbalance. Journal Clinical Immunology. 1999;93(3):302-311.
  18. Mudry P, Vavrina M, Mazanek P, Machalova M, Litzman J, Sterba J. Recurrent laryngeal papillomatosis: successful treatment with human papilloma virus vaccination. Archives of Diseasein Childhood. 2011;96(5):476-477.
  19. Sinha UK, Gallagher LA. Effects of steel scalpel, ultrasonic scalpel, CO2 laser, and monopolar and bipolar electrosurgery on wound healing in guinea pig oral mucosa. Laryngoscope. 2003;113(2):228-236.
  20. Sedlacek T. Advances in the diagnosis and treatment of human papilloma virus infections. Clinical Obstetrics Gynecology. 1996;42(2):206-222.
  21. Johnson K, Derkay C. Palliative aspects of recurrent respiratory papillomatosis. Journal Otolaryngologic Clinics of North America. 2009;42(1):57-70.
  22. Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope. 2008;118:1236-1247.
  23. Dyrstad SW, Rao KA. Recurrent respiratory papillomatosis (RRP) — juvenile onset. Clinical Medicine: Oncology. 2008;2:481-486.
  24. Zeitels SM, Barbu AM, Landau-Zemer T, Lopez-Guerra G, Burns. JA, Friedman AD, Freeman MW, Halvorsen YD, Hillman RE. Local injection of bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocalfolds: a prospective study. Annals of Otology, Rhinology and Laryngology. 2011;10:627-634.
  25. Zeitels SM. Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. Annals of Otology, Rhinology and Laryngology. 2006;115(9):679-685.
  26. Avelino MA, Zaiden TC, Gomes RO. Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis. Brazilian Journal Otorhinolaryngology. 2013;79(5):636-642.
  27. Yan Yan MD, Aleksandra E, Matthew R, Zhuang P, Charles MD, Ford N. Use of Lasersin laryngeal surgery. J of Voice. 2010;24(1):102-109.
  28. Miroshnichenko AP, Slyusarev IE, Larin AV, Shchuchkina EA, Kopaeva SV, Petrova LV. The Experience of using severnyh system sin the surgical treatmen to flaryngeal papillomatosis. Scientific-practicalconference «Modern technologies in Pediatrics». Samara. 2015. (In Russ.)
  29. Shu-yao Qiu Da-boLiu. A New Technique of Coblation usedin 42 infants with epiglottic cyst. Journal Otolaryngology. 2013;03.
  30. Temple RH, Timms MS. Paediatric coblation tonsillectomy. J Pediatr Otorhinolaryngology. 2001;61(3):195-198.
  31. Woloszko J, Kwende MM, Stalder KR. Coblation in otolaryngology. Proc SPIE. 2003;4949:341-352.
  32. Michel RM, San Giorgi, Helder HM, Lindeman R-J S, de Bock GH, Dikkers FG. The association between gastroesophageal reflux disease and recurrent respiratory papillomatosis: A systematic review. Journal yhe Laryngoscope. 2016;126(10):2330-2339.
  33. McKenna M, Brodsky L. Extraesophageal acid reflux and recurrent respiratory papilloma in children. International J of Pediatric Otorhinolaryngol. 2005;69(5):597-605.
  34. Gallagher TQ, Derkay CS. Pharmacotherapy of recurrent respiratory papillomatosis: an ex-pert opinion. Expert Opinion on Pharmacotherapy. 2009;10:645-655.
  35. Schuurman AM, Broek P. Results of treatment with alpha-interferon inadult-onset laryngeal papillomatosis. Journal Clinical Otolaryngology & Allied Sciences. 2009;11(6):447-453.
  36. Soldatsky YuL. Adjuvant therapy for recurrent respiratory papillomatosis in childhood. Pediatricheskaya farmakologiya. 2006;2:26-30. (In Russ.)
  37. Kurita T, Umeno H, Chitose S, Ueda Y, Nakashima T. Laryngeal papillomatosis: a statistical analysis of 60 cases. Nihon Jibiinkoka Gakkai Kaiho. 2015;118(3):192-200.
  38. Tsikloferon v klinicheskoi praktike. Metodicheskie rekomendatsii dlya vrachei. Pod red. Isakova V.A. SPb. 2002. (In Russ.)
  39. Romantsov MG, Kovalenko AL. Induktor interferona — tsikloferon: Itogi i perspektivy klinicheskogo primeneniya. Rekomendatsii dlya vrachei. SPb.: OOO «Semaks»; 2007. (In Russ.)
  40. Gapany M. Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study. Yearbook of Otolaryngology-Headand Neck Surgery. 2009;75-76.
  41. Akst L., Lee W, Discolo C. Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children. Archives of Otolaryngology — Head Neck Surgery. 2003;129(8):841-846.
  42. Mitrani-Rosenbaum S, Tsvieli R, Tur-Kaspa R. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. Journal of General Virology. 1989;70(8):2227-2232.
  43. Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL. Induction by estrogen metabolite 16-hydroxyestrone of genotoxic damageand aberrant proliferation in mouse mammary epithelial cells. JNCI Journal of the National Cancer Institute. 1992;84(8):634-638.
  44. Coll DA, Rosen CA, Auborn K, Potsic WP, Leon Bradlow H. Treatment of recurrent respiratory papillomatosis with indole-3-carbinol. American Journal of Otolaryngology. 1997;18(4):283-285.
  45. Rosen CA, Bryson PC. Indole-3-Carbinol for recurrent respiratory papillomatosis: long-term results. Journal of Voice. 2004;18(2):248-253.
  46. Limsukon A, Susanto I, Hoo GW, Dubinett SM, Batra RK. Regression of recurrent respiratory papillomatosis with celecoxid and erlotinid combination therapy. Chest. 2009;136(3):924-926.
  47. Wiatrak BJ, Wiatrak DW, Broker ThR, Lewis L. Recurrent Respiratory Papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Journal The Laryngoscope. 2004;114(104):1-23.
  48. Peter Kin Cho Goon, Lars-Uwe Scholtz, Holger Sudhoff. Recurrent respiratory papillomatosis (RRP) — time for a reckoning? Journal Laryngoscope Investigative Otolaryngology. 2017;2(4):184-186.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.